m+Medelevator.RU
← Поиск публикаций
Open heart · 2025

Four-dimensional flow provides incremental diagnostic value over echocardiography in aortic stenosis.

Сравнительное исследованиеСтатьяНаблюдательное исследованиеПоддержка исследования: вне правительства СШАНазвание и аннотация: Перевод пока не подготовлен
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Grafton-Clarke Ciaran, Assadi Hosamadin, Li Rui, Mehmood Zia, Hall Rimma, Matthews Gareth, Tsampasian Vasiliki, Alabed Samer, Kasmai Bahman, Staff Laura, Curtin John, Yashoda Gurung-Koney, Sun Julia, Nair Sunil, Hewson David, Thampi Kurian, Broncano Jordi, Ricci Fabrizio, Swoboda Peter, Swift Andrew J, Vassiliou Vassilios S, Geest Rob J van der, Garg Pankaj

Аннотация

AIMS: Four-dimensional flow cardiovascular MRI (4D flow CMR) has emerged as a promising technique for assessing aortic stenosis (AS). This study aimed to evaluate the agreement between 4D flow CMR and transthoracic echocardiography (TTE) in estimating peak aortic valve (AV) velocities (VPeak), grading AS severity and predicting AV intervention in a real-world setting.

METHODS: Participants from the PREFER-CMR registry who had consecutive TTE and 4D flow CMR were included. AS severity was graded using established protocols using three echocardiographic parameters (VPeak, AV area and mean pressure gradient) and CMR-derived VPeak.

RESULTS: The study recruited 30 patients (mean age 75.4 years, 67% male), with 17 undergoing AV intervention. Continuous wave Doppler (CWD) VPeak (3.4 vs 2.6 m/s, p=0.0025) and 4D flow VPeak (4.2 vs 2.7 m/s, p<0.0001) were significantly higher in patients going for AV intervention. VPeak by CWD was significantly lower to 4D flow with a bias of -0.5 (p=0.01) and a correlation of (R=0.55, p=0.002). The Cox-regression analysis reveals that 4D flow VPeak significantly predicts AV intervention (HR=2.51, p<0.01), while CWD VPeak (HR=0.54, p=0.76) shows no significant association; overall model fit is significant (χ²=9.5, p=0.02).

CONCLUSION: 4D flow CMR-derived VPeak assessment is superior to echocardiographic CWD assessment for predicting timing of AV intervention.

TRIAL REGISTRATION NUMBER: NCT05114785.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты